Evidence map›Paper›PMID 39396247›Full record

ArticleGut microbes

Maryline Roy, Anne Dumay, Sandrine Adiba, Sylvana Rozes, Seiki Kobayashi, Valérie Paradis, Catherine Postic, Dominique Rainteau, Eric Ogier-Denis, Maud Le Gall and 5 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. The gut-brain axis: mechanisms linking intestinal dysbiosis with stroke.Frontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Targeting Metabolism: Innovative Therapies for MASLD Unveiled.International journal of molecular sciences · 2025
    Review
  5. Thinking outside the brain: Gut microbiome influence on innate immunity within neurodegenerative disease.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Maryline RoyInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Anne DumayInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Sandrine AdibaDépartement de biologie, institut de Biologie de l'ENS, Ecole Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France.
Sylvana RozesInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Seiki KobayashiDepartment of Parasitology, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan.
Valérie ParadisInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Catherine PosticInstitut Cochin, CNRS, INSERM, Université Paris Cité, Paris, France.
Dominique RainteauINSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Saint Antoine Hospital, Sorbonne Université, Paris, France.
Eric Ogier-DenisInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Maud Le GallInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Ulrich MeinzerInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Emilie ViennoisInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Maite Casado-BedmarInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Alexis MoscaInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.
Jean-Pierre HugotInflammation Research Centre, UMR 1149, INSERM, Université Paris Cité, Paris, France.ORCID 0000-0002-8446-6056

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS) is a cluster of several human conditions including abdominal obesity, hypertension, dyslipidemia, and hyperglycemia, all of which are risk factors of type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease (MASLD). Dietary pattern is a well-recognized MetS risk factor, but additional changes related to the modern Western life-style may also contribute to MetS. Here we hypothesize that the disappearance of amoebas in the gut plays a role in the emergence of MetS in association with dietary changes. Four groups of C57B/6J mice fed with a high-fat diet (HFD) or a normal diet (ND) were colonized or not with

Indexed as

Diet, High-FatEntamoebaGastrointestinal MicrobiomeMetabolic SyndromeMice, Inbred C57BLAnimalsBile Acids and SaltsCytokinesDysbiosisFatty LiverLiverMaleMiceBile Acids and SaltsCytokinesamoebascAMPdysbiosisEntamoeba murishepatic steatosismetabolic dysfunction-associated steatotic liver diseaseMetabolic syndrome

Identifiers

PMID39396247
PMCPMC11485694

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.